Fig. 2From: Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancerFunctional enrichment analysis of DEGs identified in MDA-MB-231 cells. Metabolic pathways enriched with (A) upregulated (B) downregulated genes in JQ1 treatment. Metabolic pathways enriched with (C) upregulated (D) downregulated genes from JQ1 + GSK2801 combined treatmentBack to article page